Skip to content

Clinical trials

Thyroid Neoplasms trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thyroid Neoplasms Country / region: Canada Clear all

37 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20063
20072
20081
20091
20101
20112
20123
20141
20153
20162
20175
20181
20192
20212
20223
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed21
Active, not recruiting10
Recruiting4
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University Health Network, Toronto6
National Cancer Institute (NCI)4
Pfizer4
Exelixis3
AHS Cancer Control Alberta2
Eisai Inc.2
Eli Lilly and Company2
Genzyme, a Sanofi Company2
Amgen1
Apollomics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thyroid Neoplasms37
Carcinoma, Non-Small-Cell Lung10
Carcinoma, Medullary8
Melanoma8
Thyroid Cancer, Papillary8
Breast Neoplasms7
Lung Neoplasms7
Colonic Neoplasms6
Neoplasms6
Sarcoma6

Trials

Showing 51 to 37 of 37. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.